Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

FDA approves dinutuximab for high-risk paediatric neuroblastoma

FDA approves dinutuximab for high-risk paediatric neuroblastoma

Half a million children predicted to die from smoking at current rates

Half a million children predicted to die from smoking at current rates

Lung cancer survival rates in England must 'match the best in Europe' say experts

Lung cancer survival rates in England must 'match the best in Europe' say experts

FDA approves panobinostat for multiple myeloma

FDA approves panobinostat for multiple myeloma

Launch of the Immuno-Oncology Policy Action Framework

Launch of the Immuno-Oncology Policy Action Framework

$FDA approves lenvatinib for locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer$

FDA approves lenvatinib for locally recurrent or metastatic, progressive, radioactive iodine-refractory...

Short-term use of hormone replacement therapy associated with increased ovarian cancer risk

Short-term use of hormone replacement therapy associated with increased ovarian cancer risk

Abiraterone declined by Scottish Medicines Consortium for use before chemo in prostate cancer

Abiraterone declined by Scottish Medicines Consortium for use before chemo in prostate cancer

FDA approves palbociclib for treatment of ER-positive, HER2-negative advanced breast cancer in postmenopausal women

FDA approves palbociclib for treatment of ER-positive, HER2-negative advanced breast cancer in postmenopausal women

Nivolumab approved by the FDA for melanoma treatment

Nivolumab approved by the FDA for melanoma treatment

More from ecancer